Skip to Main Content
1-877-YALEMDS
1-877-YALEMDS
Phase III

REVERSE - Long COVID study

  • Study HIC#:2000041313
  • Last Updated:03/05/2026

REVERSE LC is a study to see if an FDA-approved drug called Baricitinib (ber-uh-sit-uh-nib), which is already used to treat COVID, can help improve thinking and memory problems and reduce fatigue for people who have Long COVID.

Click here to learn more: https://www.reversinglongcovid.org/

  • Age18 years and older
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Anirudh Goyal

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

CREATE A VOLUNTEER PROFILE

Eligibility Criteria

Adults 18 and older who have had thinking and memory problems for at least 6 months after a COVID-19 infection

Study link - https://www.reversinglongcovid.org/

Principal Investigator

Sub-Investigator

For more information about this study, including how to volunteer, contact:

Anirudh Goyal